Overview
Meeting: September 29 – October 1
DIA’s 2025 Latin America Annual Meeting offers unparalleled opportunities for networking and knowledge sharing with key stakeholders to advance and implement life sciences R&D initiatives in Latin America and the Caribbean. This year, session tracks on Regulatory/Clinical and Safety and Pharmacovigilance expand the scope of the meeting, with cross-track sessions facilitating discussions on key connection points across these areas to promote collaboration and synergy within organizations.
Join the conversation on multi-regional cooperation, global harmonization and reliance, lessons learned, and best practices. Don’t miss the chance to be part of this pivotal event, where innovation and cooperation come together to shape the future of healthcare in the region.
*The primary language is English, however simultaneous interpretation in Spanish and Portuguese will be available during this meeting.
While we develop our 2025 agenda, please take a moment to review the 2024 final agenda.
Participant Testimonials
DIA Latin America Annual Meeting offers unparalelled networking opportunities and knowledge sharing. It brings together outstanding scientists, impactful regulatory professionals and influential academic researchers to help advance discovery and innovation in regulatory science and policy in the LATAM region. - Viktoria Magyar, USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States
DIA offers a valuable opportunity to network with industry professionals, stay updated on the latest market trends, and gain insights into evolving regional regulations. - Jaime Cevallos, Risk Profile Technical, ARCSA, Ecuador
DIA LAAM 2024 was a great opportunity for networking and valuable insights! - Isabelle Campos, Pharmacovigilance Manager, GSK, Brazil
Program Committee
-
Flavia Firmino Ribeiro, PharmD Global Regulatory Policy Lead Latin America
Eli Lilly and Company, Brazil -
Raphael Elmadjian Pareschi, PharmD, MBA Patient Safety Lead/ Head of Pharmacovigilance Brazil
Roche, Brazil -
Daniela Bravo Regulatory Policy and Intelligence Manager
AbbVie, Brazil -
Arthur Bueno, PharmD, MBA Country Safety Head Back-Up
Sanofi Brazil, Brazil -
Martin Cabrera Carchio International Relations Advisor
ANMAT Ministry of Health, Argentina -
Johnny Karini, MD Head of Life Sciences & Health Care - US, LATAM
Tata Consultancy Services, India -
Yoon Jeon (Jamey) Kim, MSc, RPh Director, Cluster Pharmacovigilance Lead
Merck & Co., Inc., Rahway, NJ, USA, Panama -
Susan Koepke, MBA Head of Regulatory Affairs LATAM
EMD Serono, Inc., United States -
Lawrence Liberti, PhD, RAC Director, D.K. Kim International Center for Regulatory Science
The Kim Center/ USC DRQS, United States -
Mercedes Paloma Lopez, MA Regional Operations Manager, Latin America
WCG Clinical, United States -
Rosana M. Mastellaro, PharmD, RPh Director, Technical Regulatory Affairs and Innovation
Sindusfarma, Brazil -
Ana Pineda Zavaleta, MSc International Regulatory Analyst, LAO, OGPS, OPLIA, OC
FDA, United States -
Diego Alexander Salas, LLM Regulatory Affairs Director
Federación Latinoamericana de la Industria Farmacéutica, A.C., Mexico -
Carolina Sian Regulatory Affairs Manager
CAEME, Argentina -
Gislaine Villarta Capeleti Dib, PharmD Patient Safety Manager
PGA Farma, Brazil -
Bianca Zimon, LLM Health Regulation Specialist
ANVISA, Brazil -
Representative Invited Irish Dental Association, Ireland
Have an account?